Developing a vaccine to prevent HIV-1 infection
cGMP Manufacturing of Glycopeptide Immunogen Nanoparticle Vaccine
This study is working on a new vaccine to help prevent HIV-1 infection, and it may eventually involve patients in clinical trials to see how well it works and keep everyone safe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project ID | NIH-11140250 on NIH RePORTER |
What this research studies
This research focuses on creating and testing a new type of vaccine aimed at preventing HIV-1 infection. It involves the development and manufacturing of various vaccine prototypes, including DNA plasmids and viral vectors, followed by preclinical testing to ensure safety and efficacy. The research aims to streamline the process of bringing these vaccines to clinical trials, which could ultimately lead to effective prevention strategies for HIV. Patients may be involved in future clinical trials as the vaccine progresses through the testing phases.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals at high risk for HIV-1 infection or those interested in contributing to HIV vaccine research.
Not a fit: Patients who are already living with HIV or those who do not meet the eligibility criteria for clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking vaccine that significantly reduces the risk of HIV-1 infection.
How similar studies have performed: Previous research has shown promise in developing HIV vaccines using similar methodologies, indicating a potential for success in this area.
Where this research is happening
Kensington, United States
- Advanced Bioscience Laboratories, INC. — Kensington, United States (Active)
Researchers
- Principal investigator: Fouts, Timothy — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Timothy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.